Entity Common Stock, Shares Outstanding of HERON THERAPEUTICS, INC. /DE/ from 31 Jul 2011 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2011 to 13 Feb 2026.
  • HERON THERAPEUTICS, INC. /DE/ Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 188,537,136, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 188,537,136 +36,207,548 +24% 13 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 183,362,522 +31,267,610 +21% 30 Oct 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 153,291,798 +1,623,781 +1.1% 31 Jul 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 152,563,634 +1,910,476 +1.3% 01 May 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 152,329,588 13 Feb 2025 10-K 27 Feb 2025 2024 FY
Q3 2024 152,094,912 +2,022,272 +1.3% 07 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 151,668,017 +10,908,741 +7.8% 01 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 150,653,158 +31,393,843 +26% 02 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 150,072,640 +31,184,518 +26% 08 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 140,759,276 +38,127,116 +37% 25 Jul 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 119,259,315 +16,779,738 +16% 14 Mar 2023 10-K 29 Mar 2023 2022 FY
Q3 2022 118,888,122 +16,952,721 +17% 01 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 102,632,160 +722,670 +0.71% 01 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 102,479,577 +650,511 +0.64% 03 May 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 102,140,651 +10,744,142 +12% 04 Feb 2022 10-K 28 Feb 2022 2021 FY
Q3 2021 101,935,401 +11,080,147 +12% 28 Oct 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 101,909,490 +11,054,236 +12% 29 Jul 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 101,829,066 +11,186,912 +12% 04 May 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 91,396,509 +1,022,225 +1.1% 05 Feb 2021 10-K 24 Feb 2021 2020 FY
Q3 2020 90,855,254 +803,792 +0.89% 29 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 90,855,254 +11,038,837 +14% 29 Jul 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 90,642,154 +11,572,627 +15% 29 Apr 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 90,374,284 +12,192,633 +16% 03 Feb 2020 10-K 02 Mar 2020 2019 FY
Q3 2019 90,051,462 +12,032,431 +15% 30 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 79,816,417 +2,082,133 +2.7% 17 Jul 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 79,069,527 +7,118,518 +9.9% 18 Apr 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 78,181,651 +13,533,268 +21% 01 Feb 2019 10-K 22 Feb 2019 2018 FY
Q3 2018 78,019,031 +23,514,384 +43% 26 Oct 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 77,734,284 +23,595,551 +44% 24 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 71,951,009 +18,254,103 +34% 25 Apr 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 64,648,383 +11,073,849 +21% 01 Feb 2018 10-K 27 Feb 2018 2017 FY
Q3 2017 54,504,647 +15,317,053 +39% 25 Oct 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 54,138,733 +15,088,105 +39% 26 Jul 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 53,696,906 +17,038,767 +46% 17 Apr 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 53,574,534 +17,342,849 +48% 03 Feb 2017 10-K 23 Feb 2017 2016 FY
Q3 2016 39,187,594 +3,216,604 +8.9% 27 Oct 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 39,050,628 +3,364,942 +9.4% 29 Jul 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 36,658,139 +7,025,606 +24% 26 Apr 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 36,231,685 04 Feb 2016 10-K 19 Feb 2016 2015 FY
Q3 2015 35,970,990 +6,790,891 +23% 26 Oct 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 35,685,686 +6,775,033 +23% 23 Jul 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 29,632,533 +5,731,036 +24% 28 Apr 2015 10-Q 08 May 2015 2015 Q1
Q3 2014 29,180,099 -284,436,270 -91% 29 Oct 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 28,910,653 -278,058,566 -91% 29 Jul 2014 10-Q 04 Aug 2014 2014 Q2
Q1 2014 23,901,497 -281,726,796 -92% 28 Apr 2014 10-Q 12 May 2014 2014 Q1
Q3 2013 313,616,369 +11,410,814 +3.8% 31 Oct 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 306,969,219 +4,763,664 +1.6% 31 Jul 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 305,628,293 +105,582,001 +53% 30 Apr 2013 10-Q 10 May 2013 2013 Q1
Q3 2012 302,205,555 +102,187,759 +51% 31 Oct 2012 10-Q 05 Nov 2012 2012 Q3
Q2 2012 302,205,555 +102,187,759 +51% 31 Jul 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 200,046,292 30 Apr 2012 10-Q 10 May 2012 2012 Q1
Q3 2011 200,017,796 31 Oct 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 200,017,796 31 Jul 2011 10-Q 08 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.